Audio Clinical Professionals

Myasthenia Gravis Maintenance Therapy and Targets

Explains IVIG effective in mild or ocular myasthenia gravis, hospitalization duration in myasthenic crisis, and treatment goals for myasthenia gravis in practical Neuromuscular Disorders care.

This resource is private and requires a subscriber login to stream. SIGN IN to continue.

Duration

00:02:44

File size

1.27 MB

Practitioner-Guided Note

Use IVIG effective in mild or ocular myasthenia gravis, hospitalization duration in myasthenic crisis, and treatment goals for myasthenia gravis to frame the working diagnosis and next step; let it drive treatment choice rather than habit. Make hospitalization duration in myasthenic crisis the checkpoint that determines whether you escalate testing, narrow the differential, or change treatment.

Key Takeaways

If you have just administered IVIG or plasma exchange, it is often wise to wait several days before introducing corticosteroids; Honestly, its efficacy is a bit up in the air and much less certain when it comes to mild or purely ocular presentations; Additionally, we want to see either a complete absence of medication side effects or only mild ones that do not require any intervention; These therapies are brought on board for individuals who are still falling short of their treatment goals even after an adequate, optimized trial of Mestinon; Primary objective is to achieve a state where the individual has no symptoms or functional limitations, though we might still detect mild weakness on a formal exam